Oxana P. Lazarenko

High Impact

Researcher

Last publication 2026 Last refreshed 2026-05-16

faculty

24 h-index 66 pubs 1,980 cited

Biography and Research Information

OverviewAI-generated summary

Oxana P. Lazarenko's research focuses on the biological mechanisms underlying bone metabolism and development, with a particular emphasis on the role of specific genes, cellular processes, and dietary factors in regulating bone density and preventing bone loss. Her work investigates how factors such as G-protein coupled receptor 109A (GPR109A), Nox4 expression in osteo-progenitors, and epigenetic modifications like H3K27me3 and H3K27ac influence osteoclastogenesis and osteoblastogenesis.

Her recent publications explore these areas through studies in mouse models, examining the impact of genetic modifications (e.g., Ezh2 myeloid cell conditional knockout, GPR109A gene deletion) and environmental factors (e.g., maternal high-fat diet, short-term increased physical activity during early life). Lazarenko also studies the effects of compounds like hippuric acid and phenolic acids on bone health, and has contributed to a longitudinal observational study on skeletal development in children with different feeding regimens. Her scholarship metrics include an h-index of 24, 66 total publications, and 1,966 total citations, designating her as a highly cited researcher. She actively collaborates with researchers at the University of Arkansas for Medical Sciences, including Jin‐Ran Chen, Michael L. Blackburn, Perry C. Caviness, and Umesh D. Wankhade.

Metrics

  • h-index: 24
  • Publications: 66
  • Citations: 1,980

Selected Publications

  • A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence (2026)
  • Soy Isoflavones Prevent Bone Quality Loss Induced by High‐Fat Diet in Rats Through Epigenetic Modifications (2025)
    1 citation DOI OpenAlex
  • Sex dependent effects of GPR109A gene deletion in myeloid cells on bone development in mice (2025)
  • Cystatin M/E Ameliorates Multiple Myeloma-Induced Hyper Osteolytic Bone Resorption (2025)
    1 citation DOI OpenAlex
  • Cystatin M/E ameliorates bone resorption through increasing osteoclastic cell estrogen influx (2024)
  • Phenolic acids prevent sex-steroid deficiency-induced bone loss and bone marrow adipogenesis in mice (2024)
    9 citations DOI OpenAlex
  • Decreased bone resorption in Ezh2 myeloid cell conditional knockout mouse model (2023)
    11 citations DOI OpenAlex
  • A longitudinal observational study of skeletal development between ages 3 mo and 6 y in children fed human milk, milk formula, or soy formula (2023)
    5 citations DOI OpenAlex
  • Maternal high-fat diet modifies epigenetic marks H3K27me3 and H3K27ac in bone to regulate offspring osteoblastogenesis in mice (2022)
    11 citations DOI OpenAlex
  • Nox4 expression in osteo-progenitors controls bone development in mice during early life (2022)
    16 citations DOI OpenAlex
  • GPR109A gene deletion ameliorates gonadectomy-induced bone loss in mice (2022)
    5 citations DOI OpenAlex
  • <scp>Short‐Term</scp> Increased Physical Activity During Early Life Affects High‐Fat <scp>Diet–Induced</scp> Bone Loss in Young Adult Mice (2021)
    4 citations DOI OpenAlex
  • Ezh2 mediates epigenetic regulation of osteoclastogenesis and bone remodeling in mice (2021)
    1 citation DOI OpenAlex
  • GPR109A mediates the effects of hippuric acid on regulating osteoclastogenesis and bone resorption in mice (2021)
    28 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

59 Collaborators 12 Institutions 3 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics